MARKET PULSE-Aquinox, Endocyte, CommScope, Herbalife, Seagate
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s) U.S. stock index futures pointed to a slightly higher open on Friday, with major indexes on track for a week of strong gains, though geopolitical concerns remained in view as the tenuous situation in Ukraine continued. Dow Jones industrial average futures were unchanged at 0, S&P 500 futures were up 0.21 percent at 1,870.1 and Nasdaq 100 futures were up 0.26 percent at 3,701.
** ENDOCYTE INC, Thursday close $14.64, +146.11 pct premarket
The U.S. drug developer said its experimental cancer drug, when used in combination with an approved treatment, improved survival rates without the disease worsening in a mid-stage study on patients with recurrent non-small cell lung cancer.
** HERBALIFE LTD, Thursday close $50.79, -1.16 pct premarket Brokerage Argus Reasearch Co cut its rating on the nutritional supplements and weight loss product maker's stock to "hold," citing the Federal Trade Commission's investigation into the company's business practices, including its operations in China. "In view of the protracted challenges caused by the investigation and (William) Ackman's campaign against the company, we are lowering our near-term rating to hold," analyst John Staszak wrote in the note.
** MEDIA GENERAL INC, Thursday close $17.34, +15.05 pct premarket
** LIN MEDIA LLC, Thursday close $21.49, +31.46 pct premarket
Media General said it would buy LIN Media for $1.6 billion to create a broadcaster reaching nearly a quarter of U.S. households with a television.